Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Day

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Digestive Diseases and Sciences|February 28, 2016
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLDHelen L Reeves, Marco Y W Zaki, Christopher P Day
Digestive Diseases (Basel, Switzerland)|August 23, 2016
How to Diagnose Nonalcoholic Fatty Liver DiseaseNimantha M W de Alwis, Quentin M Anstee, Christopher P Day
Hepatology (Baltimore, Md.)|April 8, 2010
Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver diseaseDevanshi Seth, Ann K Daly, Paul S Haber, et al.
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver diseaseAnn K Daly, Stefano Ballestri, Lucia Carulli, et al.
Hepatology (Baltimore, Md.)|December 16, 2014
TM6SF2 as a genetic risk factor for fibrosisAnn K Daly, Christopher P Day, Yang-Lin Liu, et al.
Journal of Hepatology|January 7, 2015
Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritanceQuentin M Anstee, Yang-Lin Liu, Christopher P Day, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Gerontology|August 20, 2009
Non-alcoholic fatty liver disease in older peopleJames Frith, Christopher P Day, Elsbeth Henderson, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Digestive Diseases and Sciences|February 28, 2016
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLDHelen L Reeves, Marco Y W Zaki, Christopher P Day
Digestive Diseases (Basel, Switzerland)|August 23, 2016
How to Diagnose Nonalcoholic Fatty Liver DiseaseNimantha M W de Alwis, Quentin M Anstee, Christopher P Day
Hepatology (Baltimore, Md.)|April 8, 2010
Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver diseaseDevanshi Seth, Ann K Daly, Paul S Haber, et al.
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver diseaseAnn K Daly, Stefano Ballestri, Lucia Carulli, et al.
Hepatology (Baltimore, Md.)|December 16, 2014
TM6SF2 as a genetic risk factor for fibrosisAnn K Daly, Christopher P Day, Yang-Lin Liu, et al.
Journal of Hepatology|January 7, 2015
Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritanceQuentin M Anstee, Yang-Lin Liu, Christopher P Day, et al.
European Journal of Gastroenterology & Hepatology|January 18, 2013
Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?Stuart McPherson, Quentin M Anstee, Elsbeth Henderson, et al.
Gerontology|August 20, 2009
Non-alcoholic fatty liver disease in older peopleJames Frith, Christopher P Day, Elsbeth Henderson, et al.
Journal of Hepatology|January 22, 2014
Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Elsbeth Henderson, Alastair D Burt, et al.
Gut|August 31, 2010
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseStuart McPherson, Stephen F Stewart, Elsbeth Henderson, et al.
Pageof 13